CRIS
Permanent URI for this communityhttps://scripta.up.edu.mx/handle/20.500.12552/1
Browse
2 results
Search Results
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, De-escalating treatment indications for patients who achieve metabolic goals(Elsevier, 2024) ;García-Ulloa, Ana Cristina ;Jaime-Casas, Salvador ;Rosado-Lozoya, Johanna S. ;Serrano-Pérez, Nancy H.Hernández-Juárez, DianaIntroduction: Robust evidence exists regarding initiation, intensification or modification of treatments. Recommendations to de-escalate therapy are lacking, specifically in diabetes. A successful treatment de-intensification reduces overtreatment, polypharmacy, and risk of adverse effects. Objective: To encompass current recommendations for deprescribing common drugs and create a consensus among health professionals. Methods: We reviewed four databases for deprescribing approaches published between 2010 and 2022. Articles were divided into different groups of drugs (for uric-acid, hypoglycemic, lipid-lowering, and psychotropic drugs).©Elsevier16 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, El rostro pobre de la diabetes en México(2018) ;Ramírez Sánchez, José CarlosSota Riva, Marcela De laThis paper aims at modeling the dynamics of social deprivations (SD) of the Mexican poor population in order to differentiate their material living conditions in the presence or absence of diabetes mellitus 2 (DM2). The idea is to offer evidence on the influence of some community economic and social factors in the chain of causes conditioning the development of DM2 among the poor. For this purpose, we hypothesize that the probabilities of experiencing SD in the Mexican population are higher in individuals with DM2 depending on the type of localities, SD and clinical risk factors considered. The main results drawn from a hidden Markov model support the hypothesis that a part of the poor population, which is rural and diabetic, is the one with the highest probability (current and future) of experiencing sd in Mexico. ©2018 Universidad Nacional Autónoma de México.Scopus© Citations 1 13 2
